Drug-off Criteria in Patients with Hepatocellular Carcinoma who Achieved Clinical Complete Response after Combination Treatment with Immunotherapy and Locoregional Therapy

被引：3
|
作者：
Kudo, Masatoshi [1 ,2 ]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, Liver Canc, Osakasayama, Japan
[2] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 337-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan
来源：
LIVER CANCER | 2023年 / 12卷 / 04期
关键词：
hepatocellular carcinoma; systemic therapy; locoregional therapy; clinical complete response; drug-off criteria; CONTRAST-ENHANCED ULTRASOUND; ATEZOLIZUMAB PLUS BEVACIZUMAB; RADIOFREQUENCY ABLATION; LIVER RESECTION; VEIN INVASION; SORAFENIB; ULTRASONOGRAPHY; LENVATINIB; SONOGRAPHY; MANAGEMENT;
D O I：
10.1159/000532023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：289 / 296
页数：8
相关论文
共 50 条
  • [31] Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy
    Chao, Yin-Kai
    Chuang, Wen-Yu
    Yeh, Chi-Ju
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (01) : 201 - 208
  • [32] Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy
    Makiyama, A
    Itoh, Y
    Kasahara, A
    Imai, Y
    Kawata, S
    Yoshioka, K
    Tsubouchi, H
    Kiyosawa, K
    Kakumu, S
    Okita, K
    Hayashi, N
    Okanoue, T
    [J]. CANCER, 2004, 101 (07) : 1616 - 1622
  • [33] Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy
    Basso, M
    Torre, F
    Picciotto, A
    [J]. CANCER, 2005, 103 (12) : 2654 - 2655
  • [34] Clinical outcomes in patients who develop hepatocellular carcinoma after hepatitis C viral eradication by antiviral therapy
    Tsuchiya, Kaoru
    Yasui, Yutaka
    Tamaki, Nobuharu
    Suzuki, Shoko
    Hosokawa, Takanori
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Asahina, Yasuhiro
    Izumi, Namiki
    [J]. HEPATOLOGY, 2014, 60 : 861A - 861A
  • [35] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Imamura, Michio
    Nakamura, Yuki
    Morio, Kei
    Nakahara, Takashi
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Chayama, Kazuaki
    Miki, Daiki
    [J]. HEPATOLOGY, 2017, 66 : 629A - 629A
  • [36] Hepatocellular carcinoma development in hepatitis C virus patients who achieved sustained viral response by interferon therapy and direct anti-viral agents therapy
    Nagaoki, Yuko
    Aikata, Hiroshi
    Kobayashi, Tomoki
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Chayama, Kazuaki
    [J]. HEPATOLOGY, 2016, 64 : 424A - 424A
  • [37] Active Surgery Did Not Benefit Patients with Locally Advanced Rectal Cancer Who Achieved Clinical Complete Response after Neoadjuvant Chemoradiotherapy
    Gu, Jin
    Han, Zihan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E9 - E9
  • [38] Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy
    Takahashi, Shunsuke
    Kudo, Masatoshi
    Chung, Hobyung
    Inoue, Tatsuo
    Ishikawa, Emi
    Kitai, Satoshi
    Tatsumi, Chie
    Ueda, Taisuke
    Minami, Yasunori
    Ueshima, Kazuomi
    Haji, Seiji
    [J]. ONCOLOGY, 2007, 72 : 98 - 103
  • [39] Comparison of PERCIST and RECIST criteria for evaluation of therapy response after yttrium-90 microsphere therapy in patients with hepatocellular carcinoma and those with metastatic colorectal carcinoma
    Sager, Sait
    Akgun, Elife
    Uslu-Besli, Lebriz
    Asa, Sertac
    Akovali, Burak
    Sahin, Onur
    Yeyin, Nami
    Demir, Mustafa
    Abuqbeitah, Mohammad
    Gulsen, Fatih
    Sayman, Haluk
    Sonmezoglu, Kerim
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (05) : 461 - 468
  • [40] ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
    Sawaki, Masataka
    Kataoka, Ayumi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (06) : 3233 - 3234
12345